See the DrugPatentWatch profile for Thalidomide
Is thalidomide still under patent protection?
Thalidomide is an old drug, and its original patents have long since expired in most major markets. What matters today is not the original thalidomide patent, but newer patent protections that may cover specific formulations, methods of use, or follow-on products in particular countries.
What patents cover thalidomide products today?
Even when the core active ingredient is off-patent, companies can still obtain protection for things like:
- Specific ways of using thalidomide in combination regimens
- Particular dosage forms or manufacturing processes
- New formulations (where a product improves stability, delivery, or bioavailability)
These protections are product- and jurisdiction-specific, so the remaining rights depend on the country and the exact product name.
When did thalidomide’s original patents expire?
The original thalidomide patents are historical and have expired long ago, which is why thalidomide is widely available as a generic medicine in many places. Exact expiry dates vary by patent family and by jurisdiction, so published patent records for each country are needed to state a specific date.
Why do people still search “thalidomide patent” if the drug is old?
Search interest often comes from confusion between:
- The original thalidomide molecule patent (expired)
- Later patents tied to specific approved indications (for example, in multiple myeloma) and combinations
- Country-by-country exclusivity periods or regulatory data protections that can affect market entry even after classic patents expire
Can generics enter without waiting for thalidomide patents?
In general, generics can enter once relevant patents and exclusivity protections for the specific product/formulation/approved use are no longer in force. If a later “follow-on” patent exists for a particular use or formulation in a given country, that can delay market entry for certain generic versions.
Where can I check the exact status for a specific country or product?
To determine the current patent/exclusivity status, you typically need:
- The exact brand or generic product name
- The country/region (for example, US, EU member state, UK, India)
- Patent database search results for that drug and product-specific patent families
If you tell me the country (and the product name if you have one), I can help you identify what to look for (molecule vs formulation vs method-of-use patents, and what would block generic entry).
Sources
No sources were provided in the prompt, so I can’t cite specific patent or regulatory records here.